Jack Henkin
17Patents
6h-index
40Co-inventors
66Inventor score
Filing activity: Mar 16, 1998 → Mar 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5932545A | Antiangiogenic drug to treat cancer, arthritis and retinopathy | Emerging Cross-Sectional Technologies | 48 | Expired |
| US6242494A | Substituted .beta.-amino acid inhibitors of methionine aminopeptidase-2 | Chemistry; Metallurgy | 29 | Expired |
| US7030262B2 | 3-Amino-2-hydroxyalkanoic acids and their prodrugs | Chemistry; Metallurgy | 28 | Expired |
| US7491718B2 | Sulfonamides having antiangiogenic and anticancer activity | Chemistry; Metallurgy | 25 | Expired |
| US6288228A | Triazine angiogenesis inhibitors | Chemistry; Metallurgy | 24 | Expired |
| US6150362A | Triazine angiogenesis inhibitors | Chemistry; Metallurgy | 13 | Expired |
| US6632961B1 | Antiangiogenic drug to treat cancer, arthritis and retinopathy | Chemistry; Metallurgy | 5 | Expired |
| US6849757B2 | Antiangiogenic drug to treat cancer, arthritis and retinopathy | Chemistry; Metallurgy | 4 | Expired |
| US6716963B1 | Peptide antiangiogenic drugs | Chemistry; Metallurgy | 3 | Expired |
| US10583199B2 | Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs | Human Necessities | 2 | Active |
| US6774211B1 | Peptide antiangiogenic drugs | Chemistry; Metallurgy | 2 | Expired |
| US6753408B1 | Peptides having antiangiogenic activity | Chemistry; Metallurgy | 1 | Expired |
| US10081668B2 | Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection | Human Necessities | 1 | Active |
| US11261237B2 | Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection | Human Necessities | 0 | Active |
| US11207423B2 | Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs | Human Necessities | 0 | Active |
| US6777535B1 | N-alkylated peptides having antiangiogenic activity | Human Necessities | 0 | Expired |
| US7432245B2 | Pharmaceutical formulation comprising a peptide angiogenesis inhibitor | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.